what is the difference between zepbound and compounded tirzepatide vs Mounjaro/Zepbound: 75% Cheaper Navigating Regulatory Shifts: Alternatives to
Description
Over two percent of adult patients now take a GLP-1 drug to treat overweight or obesity, according to a FAIR Health white paper entitled, Obesity and GLP-1 Drugs: A Claims-Based Analysis
Buy Retatrutide (GLP-3)
Mok J et al
These incidents became much more common after the FDA started approving GLP-1 drugs for chronic weight management in 2021.
With its higher comparative efficacy, Mounjaro launched at just the right time: public awareness of GLP-1s was increasing and demand skyrocketed
